Gallstone disease overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 29: Line 29:


==Epidemiology and Demographics==
==Epidemiology and Demographics==
Gallstone disease has an overall higher prevalence in females than males of the Western Caucasian, Hispanic and Native American nations. Approximately 62 people will have gallstones per 100,000 worldwide.
Gallstone disease has an overall higher [[incidence]] in females than males of the Caucasian, Hispanic and Native American nations. Whilst a lower incidence was found in Eastern European, African American, and Japanese populations. Approximately 6200 people will have gallstones per 100,000 worldwide.


==Risk Factors==
==Risk Factors==
Common risk factors in the development of gallstone disease include age, sex, pregnancy, and oral contraceptives and estrogen replacement therapy. Less common risk factors include obesity, sudden weight loss and diabetes.
Common risk factors in the development of gallstone disease include [[Ageing|age]], sex, [[pregnancy]], and [[Oral contraceptive|oral contraceptives]] and estrogen replacement therapy. Less common risk factors include hepatic and biliary [[cirrhosis]].


==Screening==
==Screening==
Early treatment of gallstone disease decreases the morbidity and avoids further cholecystectomy, which in turn may offset the need for screening. However, periodic screening may be useful within the diabetic population. Therefore, there is insufficient evidence to recommend routine screening for Gallstone disease.
Periodic screening for gallstones is not currently indicated. However, it has been suggested that screening diabetic patients for gallstones and treating them earlier is good practice for avoiding a future cholecystectomy or possible complications.


==Natural History, Complications, and Prognosis==
==Natural History, Complications, and Prognosis==
Gallstones develop in many people without causing symptoms. The chance of symptoms or complications from gallstones is about 20%. Nearly all patients (99%) who have gallbladder surgery do not have their symptoms return.
Gallstone disease patients should not undergo an elective [[cholecystectomy]] until symptoms develop, since almost 55% of patients will remain [[asymptomatic]]. Also, the [[Complication (medicine)|complications]] of [[asymptomatic]] gallstones are almost negligible unless symptoms develop. The complications of gallstone disease include [[acute cholecystitis]], [[Jaundice|obstructive jaundice]], acute [[cholangitis]] and acute [[pancreatitis]]. The prognosis after [[Cholecystectomy|laparoscopic cholecystectomy]] is excellent with [[morbidity]] and [[Mortality rate|mortality]] rates being as low as 0.5 and 10% respectively.
 
 
===Diagnosis===
===Diagnosis===



Revision as of 20:34, 7 December 2017

https://https://www.youtube.com/watch?v=UPw3ot1M_o0%7C350}}

Gallstone disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Gallstone disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Lithotripsy
Surgical management

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Gallstone disease overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gallstone disease overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gallstone disease overview

CDC on Gallstone disease overview

Gallstone disease overview in the news

Blogs on Gallstone disease overview

Directions to Hospitals Treating Gallstone disease

Risk calculators and risk factors for Gallstone disease overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]

Overview

Gallstone disease is the presence of gallstones (cholelithiasis) within the gallbladder —chole- means "bile", lithia means "stone", and -sis means "process". Gallstones are crystalline bodies formed within the body by concretion of normal or abnormal bile components. Gallstones can occur anywhere within the biliary tree, including the gallbladder and the common bile duct. Obstruction of the common bile duct is called choledocholithiasis, obstruction of the biliary tree can cause jaundice and obstruction of the outlet of the pancreatic exocrine system can cause pancreatitis.

Historical Perspective

Gallstone disease has been noted as far back as when Egyptian pharaohs ruled. Autopsies performed on mummies found gallstones present within the body cavities.

Classification

Gallstone disease may be classified according to the chemical analysis of the stone found into 3 subtypes/groups: pure cholesterol, pure bilirubin stones and mixed.

Pathophysiology

It has long been noted that gallbladder stone formation, and in particular cholesterol stones, are associated with bile supersaturation, and this still remains the most common cause for gallstone formation.

Causes

Common causes of gallstone disease include increasing age, pregnancy, oral contraceptive pills and obesity.

Differentiating Gallstone disease overview from Other Diseases

Gallstone disease must be differentiated from other diseases that cause right upper quadrant pain such as: gastroesophageal reflux disorder, peptic ulcer disease, hepatitis, sphincter of Oddi dysfunction, appendicitis, bile duct stricture, chronic pancreatitis, irritable bowel syndrome, ischemic heart disease, pyelonephritis, ureteral calculi and complications of gallstone disease include: acute cholecystitis, choledocholithiasis, acute pancreatitis, and acute cholangitis.

Epidemiology and Demographics

Gallstone disease has an overall higher incidence in females than males of the Caucasian, Hispanic and Native American nations. Whilst a lower incidence was found in Eastern European, African American, and Japanese populations. Approximately 6200 people will have gallstones per 100,000 worldwide.

Risk Factors

Common risk factors in the development of gallstone disease include age, sex, pregnancy, and oral contraceptives and estrogen replacement therapy. Less common risk factors include hepatic and biliary cirrhosis.

Screening

Periodic screening for gallstones is not currently indicated. However, it has been suggested that screening diabetic patients for gallstones and treating them earlier is good practice for avoiding a future cholecystectomy or possible complications.

Natural History, Complications, and Prognosis

Gallstone disease patients should not undergo an elective cholecystectomy until symptoms develop, since almost 55% of patients will remain asymptomatic. Also, the complications of asymptomatic gallstones are almost negligible unless symptoms develop. The complications of gallstone disease include acute cholecystitisobstructive jaundice, acute cholangitis and acute pancreatitis. The prognosis after laparoscopic cholecystectomy is excellent with morbidity and mortality rates being as low as 0.5 and 10% respectively.

Diagnosis

History and Symptoms

The diagnosis of uncomplicated gallstone disease is made in a patient who may be asymptomatic or experiencing biliary colic with a normal physical examination and normal laboratory tests including complete blood count, aminotransferases, bilirubin, alkaline phosphatase, amylase, and lipase.Typically, the evaluation begins with a transabdominal ultrasound since it is the most sensitive modality for detecting gallbladder stones. Most patients are females over the age of 40 whom have had multiple children and tend to have a BMI over 25.

Physical Examination

Patients with gallstones are usually not ill-appearing and don't have fever or tachycardia. Physical examination of patients with gallstones is sometimes remarkable for right upper quadrant pain, epigastric tenderness, guarding and jaundice. This occurs when stone reach more than 8mm in size. Courvoisier's sign (a palpable gallbladder on physical examination) may be palpated when the common bile duct becomes obstructed and the gallbladder becomes dilated. This mostly occurs with malignant common bile duct obstruction, but has been reported with choledocholithiasis

Laboratory Findings

Laboratory findings are usually normal among patients with uncomplicated gallstone disease, both during asymptomatic periods and during attacks of pain. Abnormal blood tests (leukocytosis, elevated liver or pancreas tests) suggest the development of a complication of gallstone disease, such as cholecystitis, cholangitis, or pancreatitis

Imaging findings

Stones are mainly visualised using transabdominal ultrasonography.

Other diagnostic studies

There are other imaging modalities that can be useful in diagnosing gallstone disease, these include; endoscopic retrograde cholangiopancreatography (ERCP), bile microscopy and oral cholecystography. It should be noted however, that some of these have been replaced by non-invasive, more advanced and less expensive imaging technique

Treatment

Medical Therapy

Nonoperative management is suboptimal (ursodiol, lithotripsy). Cholecystectomy is the therapy of choice.

Surgery

Surgery is not the first-line treatment option for patients with asymptomatic gallstones. Surgery is usually reserved for patients with either symptomatic gallstones and willing to undergo surgery, had complications due to gall stones or are at risk of gallbladder cancer, and having symptomatic recurrent attacks.

Primary Prevention

Effective measures for the primary prevention of gallstone disease include diet with sufficient fat and protein, maintaining a low body weight, and avoiding prolonged fasting.

Secondary Prevention

Effective measures for the secondary prevention of gallstone disease include dietary measures and bile acid therapy. However, medical therapy of asymptomatic stones is not currently indicated.

References

Template:WH Template:WS